![Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-018-0715-8/MediaObjects/12935_2018_715_Fig2_HTML.png)
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text
![Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition](https://www.spandidos-publications.com/article_images/ol/19/2/ol-19-02-1487-g03.jpg)
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
![A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523314001247-gr4.jpg)
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect
![Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/86378b78-3bcb-4baf-b366-788bbf8303d2/gr1.jpg)
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer | Scientific Reports High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-68150-8/MediaObjects/41598_2020_68150_Fig3_HTML.png)
High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer | Scientific Reports
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ] HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png)
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig6_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig3_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig5_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig1_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition](https://www.spandidos-publications.com/article_images/ol/19/2/ol-19-02-1487-g01.jpg)
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
![PDF) Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers PDF) Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers](https://i1.rgstatic.net/publication/5503734_Meta-analysis_of_Colorectal_Cancer_Gene_Expression_Profiling_Studies_Identifies_Consistently_Reported_Candidate_Biomarkers/links/56ca4ecd08ae5488f0d94908/largepreview.png)
PDF) Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers
![An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09169-0/MediaObjects/12885_2022_9169_Fig4_HTML.png)
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
![Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition](https://www.spandidos-publications.com/article_images/ol/19/2/ol-19-02-1487-g00.jpg)
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
![A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523314001247-gr1.jpg)
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect
![Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-018-0715-8/MediaObjects/12935_2018_715_Fig1_HTML.png)
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text
![A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523314001247-gr2.jpg)